Navigation Links
Australia to Show Leniency towards U.S. Pharmaceutical Companies

Australian would remove the amendment which states to reduce the price of the drug obtained from US.

The Trade Minister and the // acting Prime Minister Mark Vaile reported that this amendment was accepted because it was supported by the major opposition party in Australia (Labor Party).

The reason that the party supported the amendment was to prevent the delay in the introduction of new generic drugs.

According to the amendment the Australian authorities have the power to levy heavy fines and ask the pharmaceutical company to reimburse for the lost sales.

Apart from that the company has to pay extra cash to the federal and state government. This amendment became a law and was in function from the first of January 2005.

But the Australian government also considers the risks the pharmaceutical company has to face and has told that this act would be reviewed.

The government told the companies that the act would be removed if the companies proved that the act has been misused by the Australian government.

But still the Australian government still wishes that both the parties discuss on this issue and come out with a better law which would not be detrimental to both the Australian government and the pharmaceutical companies.

He also mentioned that the pharmaceutical companies can delay their patents only if there is an enhancement in the profits due to the drug.

But the government will never allow the misuse of the law at any cost.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia awaits US FDA reports on ADHD drugs
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors

Post Your Comments:
(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)... Voyant Health™ announced today that Sp...d its TraumaCad Enterprise orthopedic templating s.... , (PRWEB) November 27, ...Spectrum Health (Grand Rapids, Michigan) has licen... solution and its TraumaCad Extend workflow soluti...
(Date:11/26/2009)...27/PRNewswire/--Withcoldandfluseasonuponus,it,smor...espreadofinfectionsandavoidillness. ,, "Weneedt...idtransmittingillnessifwe,resick,"saidEileenFinert...irectorforinfectioncontrolandoccupationalhealthatH...spitalforSpecialSurgeryhasoneofthelowestinfectionr...
(Date:11/26/2009)...ig or too heavy can lead to strains or worse , ...re may be nothing wrong with stuffing your turkey ... same thing with your suitcase as you pack for hol...ted in 2008 in U.S. hospital emergency rooms, doct... for luggage-related injuries, such as muscle stra...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leadi..., today announced the expansion of its services to..., Dr. Doug Macmillan. , ...s pleased to announce that Dr. Doug Macmillan, an ...d an additional advanced training seminar. RTDent...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...ds were missed, could be more prominent , ...Bix brought home a bottle of over-the-counter pain...t the bottle did not have a child-resistant cap on...of any product line can be exempted from the feder...
...inityCare Senior Living, Inc. (OTC Bulletin Board:...ed senior living facilities, today announced that ...p and implement a comprehensive investor relations...mall-cap companies with the potential to outperfor...
...age in Maple Lake, Minn., is hosting an Open House...the general public interested in learning more abo...ill be on hand to give tours and answer questions ...ns. , , Courage Center Camps offer safe, accessib...
...March 30, 2009 A study published in a special iss...he emerging practice of drug delivery systems whic...ions in the body. , The process uses biocompatib...s can be used to achieve control of the delivery. ...
...r Products (NYSE: APD ) has named John W. Marsla...id Bulk, Generated Gases, and Helium, effective Ap...e leadership and management of the businesses that...e he led the company,s efforts to streamline busin...
... a need for more trained professionals to understa...ultural contexts, conflict, poverty, and natural d...hology is chartering the nation,s first Ph.D. in ...ost-master,s doctoral degree will leverage The Chi...
Other Medicine News:Health News:Labels on OTC Painkillers Need Improvement 2Health News:Labels on OTC Painkillers Need Improvement 3Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 2Health News:TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel 3Health News:Camp Courage Hosts Open House Sunday, April 26 2Health News:Air Products Appoints John Marsland VP and GM of Global Liquid Bulk, Generated Gases, and Helium 2Health News:Chicago School of Professional Psychology Announces New Ph.D. in International Psychology 2Health News:Chicago School of Professional Psychology Announces New Ph.D. in International Psychology 3
(Date:11/27/2009)...27/PRNewswire/--ACUOTECHNOLOGIES,developersofhigh-...ationtoolsandservices,ispleasedtoannouncethattheUn...ntapplicationforan"AssetCommunicationFormatwithina...U.S.patenttoitsportfolioofintellectualproperty.Ing...cuo,stechnologyanduseofassetmetainformationtocontr...
(Date:11/26/2009)...ica,Nov.26/PRNewswire/--The2009Frost&SullivanS...euticalMarketispresentedtoCiplaMedproSouthAfricaLi.../prnh/20081117/FSLOGO ) ,, FortheCompanyoftheYe...laMedpro,sperformanceagainstkeycompetitors:growths...essprocesses,productsand/ortechnologiesandleadersh...
(Date:11/25/2009)...PRNewswire-FirstCall/--AmericanScientificResources...uncethattheyhaveopenedaregionalmarketingandproduct...eenabletosecurealocationabroad,providinganessentia...futurehealthandsafetyproductsforchildrenandadultst...ousesinventoryinthestateofOhiowheretheywillalsobea...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3American Scientific Resources Inc. Opens Shanghai Location 2RNs Praise House Vote to Permit State Single Payer Laws 52009 1RNs Praise House Vote to Permit State Single Payer Laws 52009 2RNs Praise House Vote to Permit State Single Payer Laws 52009 3Five Hypertension Genes Found in Black Americans 52006 1Five Hypertension Genes Found in Black Americans 52006 2Five Hypertension Genes Found in Black Americans 52006 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 1Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 4
... France, September 1 The ERATO study,published to...r the first,time in patients with permanent atrial...icantly reduces mean 24 hour ventricular rate, on ...ate reduction was 11.7 beats per,minute (p< 0,... is,clinically relevant and highly statistically s...
...alysis of landmark trial showed prasugrel substant...mbosis compared with clopidogrel among ...rmany, Aug. 31 Patients who were,diabetic and dia... percent,less likely to suffer a heart attack if t...ccording to a sub-group analysis of the TRITON-TIM...
Other Medicine Technology:American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 2American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 2Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 4Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 5
Streck-CN free Lyse CD Lytic Reagent
... and CVA for CELL-DYN are assayed linearity contro...verify patient reportable range of three- and five...e the linear performance of the analyzer. CVA and ...priate for each instrument model and provide instr...
LATITUDE® Patient Management System
...roprietary EX.P.R.T. Release Technology essentiall..., No stent shortening,, Unique anatomical...rotid bifurcation,, 0.014 Rapid Exchange ca... atraumatic tip,, Radiopaque marker on cath...
Medicine Products: